Skip to main content

Table 2 Dose distribution for ten most frequently used antipsychotics during stable-dose period among case and control cohorts

From: Hospital utilization rates following antipsychotic dose reductions: implications for tardive dyskinesia

Drug

Case (N, %)

Case Stable Dose (mg), Mean ± SD

Control (N, %)

Control Stable Dose (mg), Mean ± SD

Risperidone

4564 (23.3)

7 ± 7

4135 (21.1)

5 ± 6

Quetiapine

3871 (19.8)

463 ± 278

3226 (16.5)

331 ± 254

Olanzapine

2558 (13.1)

22 ± 13

2422 (12.4)

17 ± 12

Aripiprazole

1838 (9.4)

29 ± 47

2712 (13.9)

22 ± 38

Paliperidone

1180 (6.0)

70 ± 68

1704 (8.7)

56 ± 63

Haloperidol

1472 (7.5)

31 ± 30

1396 (7.1)

22 ± 19

Ziprasidone

1185 (6.1)

147 ± 61

1026 (5.2)

125 ± 55

Clozapine

1251 (6.4)

407 ± 180

683 (3.5)

405 ± 190

Lurasidone

467 (2.4)

93 ± 42

820 (4.2)

68 ± 35

Fluphenazine

301 (1.5)

20 ± 13

277 (1.4)

15 ± 11

  1. SD standard deviation